Limitations of Analyses Based on Achieved Blood Pressure
Authors:
- Esa M. DavisEDEsa M. Davis
- Lawrence J. AppelLALawrence J. Appel
- Xuelei WangXWXuelei Wang
- Tom GreeneTGTom Greene
- Brad C. AstorBABrad C. Astor
- Mahboob RahmanMRMahboob Rahman
- Robert TotoRTRobert Toto
- Michael S. LipkowitzMLMichael S. Lipkowitz
- Velvie A. PogueVPVelvie A. Pogue
- Jr Jackson T. WrightJWJr Jackson T. Wright
- for the African American Study of Kidney DiseaseFDfor the African American Study of Kidney Disease
- Hypertension Research Collaborative GroupHGHypertension Research Collaborative Group
- 1 June 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (6) , 1061-1068
Abstract
Blood pressure (BP) guidelines that set target BP levels often rely on analyses of achieved BP from hypertension treatment trials. The objective of this article was to compare the results of analyses of achieved BP to intention-to-treat analyses on renal disease progression. Participants (n=1094) in the African-American Study of Kidney Disease and Hypertension Trial were randomly assigned to either usual BP goal defined by a mean arterial pressure goal of 102 to 107 mm Hg or lower BP goal defined by a mean arterial pressure goal of ≤92 mm Hg. Median follow-up was 3.7 years. Primary outcomes were rate of decline in measured glomerular filtration rate and a composite of a decrease in glomerular filtration rate by >50% or >25 mL/min per 1.73 m 2 , requirement for dialysis, transplantation, or death. Intention-to-treat analyses showed no evidence of a BP effect on either the rate of decline in glomerular filtration rate or the clinical composite outcome. In contrast, the achieved BP analyses showed that each 10-mm Hg increment in mean follow-up achieved mean arterial pressure was associated with a 0.35 mL/min per 1.73 m 2 (95% CI: 0.08 to 0.62 mL/min per 1.73 m 2 ; P =0.01) faster mean glomerular filtration rate decline and a 17% (95% CI: 5% to 32%; P =0.006) increased risk of the clinical composite outcome. Analyses based on achieved BP lead to markedly different inferences than traditional intention-to-treat analyses, attributed in part to confounding of achieved BP with comorbidities, disease severity, and adherence. Clinicians and policy makers should exercise caution when making treatment recommendations based on analyses relating outcomes to achieved BP.Keywords
This publication has 34 references indexed in Scilit:
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trialJournal Of Hypertension, 2006
- Association of Achieved Dialysis Dose with Mortality in the Hemodialysis StudyJournal of the American Society of Nephrology, 2005
- Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy TrialJournal of the American Society of Nephrology, 2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Effects of Blood Pressure Control on Progressive Renal Disease in Blacks and WhitesHypertension, 1997
- Analysis as‐randomized and the problem of non‐adherence: An example from the veterans affairs randomized trial of coronary artery bypass surgeryStatistics in Medicine, 1993
- Analysis of clinical trials by treatment actually received: Is it really an option?Statistics in Medicine, 1991